Imricor Medical Systems' (ASX:IMR) second-quarter net loss was $7.4 million, compared with $7.8 million in the prior-year quarter, according to a Monday Australian bourse filing.
Revenue for the three months ended June 30 came in at $60,500, compared with $65,200 in the year-ago period, the medical device company said.
The company said it is expanding its US commercial team, with additional hires to be added during the September and December quarters to cover new regions of the US.
Imricor Medical Systems' shares rose nearly 3% in recent trading on Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments